Open access
Aug 2026
Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes.
AIMS To further characterise the effects of retatrutide on cardiometabolic risk, lipoprotein and inflammatory biomarkers were assessed post hoc in phase 2 trials of adults with obesity/overweight with or without type 2 diabetes (T2D). MATERIALS AND METHODS Data were analysed from two randomised, double-blind, placebo...
G. Ruotolo, C. Harris, Yanzhu Lin et al.
· Diabetes, obesity and metabo... · 0 citations